← United States · All US Insider Profiles

US INSIDER PROFILE · NON-SCORING RESEARCH

KUMAR AMIT

Chief Executive Officer | Officer

Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001191905

Purchase history

Companies traded
1
Purchases · 12M
10
Purchases · 24M
14
Average purchase
$24.2K
Median purchase
$16.5K
Gross purchase value
$338.9K

Companies: Anixa Biosciences Inc

14 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.

Qualifying purchase disclosures

PublishedCompanyTickerRoleReported valueSEC source
2026-09-28Anixa Biosciences IncANIXChief Executive Officer | Officer$19.5KOpen filing
2026-09-14Anixa Biosciences IncANIXChief Executive Officer | Officer$8.2KOpen filing
2026-09-11Anixa Biosciences IncANIXChief Executive Officer | Officer$13.8KOpen filing
2026-08-03Anixa Biosciences IncANIXChief Executive Officer | Officer$17.4KOpen filing
2026-07-28Anixa Biosciences IncANIXChief Executive Officer | Officer$17.2KOpen filing
2026-07-27Anixa Biosciences IncANIXChief Executive Officer | Officer$11.2KOpen filing
2026-07-27Anixa Biosciences IncANIXChief Executive Officer | Officer$10.7KOpen filing
2026-07-21Anixa Biosciences IncANIXChief Executive Officer | Officer$17.3KOpen filing
2026-07-13Anixa Biosciences IncANIXChief Executive Officer | Officer$15.2KOpen filing
2026-06-16Anixa Biosciences IncANIXChief Executive Officer | Officer$52.5KOpen filing
2025-07-31Anixa Biosciences IncANIXChief Executive Officer | Officer$15.8KOpen filing
2025-07-14Anixa Biosciences IncANIXChief Executive Officer | Officer$15.8KOpen filing
2025-06-05Anixa Biosciences IncANIXChief Executive Officer | Officer$28.5KOpen filing
2025-01-15Anixa Biosciences IncANIXChief Executive Officer | Officer$95.9KOpen filing

Post-purchase outcomes

Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.

PeriodCompleted eventsPrice coverageHit rateMedian excess returnAverage excess returnWorst excess return
5D14Developing100.0% (14/14)50.0% (7/14)+0.2%+3.8%-7.2%
20D13Developing100.0% (13/13)61.5% (8/13)+1.3%+4.2%-9.9%
60D6Developing85.7% (6/7)83.3% (5/6)+12.3%+11.7%-5.6%
120D4Small Sample100.0% (4/4)50.0% (2/4)+14.9%+14.0%-11.2%

Research patterns

First purchase in 12M
0/13
Large purchase ≥ $100k
0/14
Cluster buying · 15D
9/14
Buying the dip
14/14

Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.

Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.